Kim Hae Won, Hai Chi-Ming, Greenburg A Gerson
Department of Molecular Pharmacology, Physiology and Biotechnology Brown University, 171 Meeting Street, Providence, RI 02912, USA.
Artif Cells Blood Substit Immobil Biotechnol. 2010;38(1):5-12. doi: 10.3109/10731190903495694.
In addition to heme-irons, reactive (beta-globin thiols (betaCys93s) of hemoglobin (Hb) also have been shown to interact with endogenous nitric oxide (NO) thereby contributing to vascular tone regulation. What relative roles do these NO binding sites contribute to the overall Hb-mediated vasoactivity? Several test Hbs with either or both the NO binding sites preliganded or blocked were prepared and tested in a rat thoracic aortic ring model. Hbs tested were: NEM-Hb (ferrous Hb with masked thiols), HbNO (ferrous Hb preliganded with NO), Hb(+)CN (ferric Hb liganded with CN(-)), NEM-HbNO and NEM-Hb(+)CN (Hbs with both heme-iron and cysteine sites preliganded or blocked). Typically, >0.2 microM control Hb significantly increased isometric tension in agonist stimulated vessel rings (58.1 +/-7.0% over baseline). At comparable concentrations, NEM-Hb also caused a significant contraction (50.7+/-9.5%) while HbNO and Hb(+)CN did not (-5.5+/-6.0% and -3.7+/-4.6%, respectively). For these Hbs, masking thiols as well did not significantly alter respective vascular effects. Ferrous sperm whale myoglobin (Mb), which has no reactive thiol, elicited a significant contraction (55.1+/-13.2%) while metMb did not (-0.8+/-3.2%), suggesting the relative importance of heme-iron ligand and oxidation state in Hb vasoactivity. Additionally, ferrous or ferric equine heart cytochrome-C, a heme protein with no readily available heme-iron and cysteine binding sites, did not elicit notable contraction. Human Hb variants in which (betaCys93s are deleted or substituted with non-cysteine residues did not reveal any documented significant hemodynamic abnormalities. These results indicate that reactive globin-thiols do not appear to play a prominent role relative to heme-irons in Hb-mediated vasoconstriction.
除了血红素铁之外,血红蛋白(Hb)的活性β-珠蛋白硫醇(βCys93s)也已被证明可与内源性一氧化氮(NO)相互作用,从而有助于血管张力调节。这些NO结合位点在整体Hb介导的血管活性中发挥着怎样的相对作用呢?制备了几种测试用的Hb,其NO结合位点之一或两者均预先被配体结合或阻断,并在大鼠胸主动脉环模型中进行测试。所测试的Hb包括:NEM-Hb(具有被掩盖硫醇的亚铁Hb)、HbNO(预先与NO结合的亚铁Hb)、Hb(+)CN(与CN(-)结合的高铁Hb)、NEM-HbNO和NEM-Hb(+)CN(血红素铁和半胱氨酸位点均预先被配体结合或阻断的Hb)。通常,>0.2微摩尔的对照Hb在激动剂刺激的血管环中显著增加等长张力(比基线增加58.1±7.0%)。在可比浓度下,NEM-Hb也引起显著收缩(50.7±9.5%),而HbNO和Hb(+)CN则未引起收缩(分别为-5.5±6.0%和-3.7±4.6%)。对于这些Hb,掩盖硫醇也未显著改变各自的血管效应。没有活性硫醇的亚铁抹香鲸肌红蛋白(Mb)引起显著收缩(55.1±13.2%),而高铁Mb则未引起收缩(-0.8±3.2%),这表明血红素铁配体和氧化态在Hb血管活性中的相对重要性。此外,亚铁或高铁马心脏细胞色素C,一种没有易于利用的血红素铁和半胱氨酸结合位点的血红素蛋白,未引起明显收缩。βCys93s被缺失或被非半胱氨酸残基取代的人Hb变体未显示出任何有记录的显著血液动力学异常。这些结果表明,在Hb介导的血管收缩中,相对于血红素铁而言,活性珠蛋白硫醇似乎并未发挥突出作用。